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Sevo¯urane is a rapid, potent, halogenated volatile anaesthetic with low solubility in blood. It is a non-irritant, of low pungency and children accept it easily. Therefore, sevourane is often used to induce and maintain anaesthesia in children. 1 Although sevo¯urane is generally well tolerated, adverse effects have been reported. For example, coughing, laryngospasm, agitation and excitement may occur during sevo¯urane anaesthesia. 1 In some reports of inhalation induction with high concentrations, seizure-like electrical activity or movement has been reported with an incidence of 20±88%. 2±5 However, agitation during sevo¯urane anaesthesia is not usually associated with seizures 6 and sevo¯urane is not contraindicated in patients with epilepsy. 7 Although induction of anaesthesia with sevo¯urane has been investigated extensively, less is known about the electroencephalogram (EEG) during maintenance of anaesthesia with sevo¯urane. In our hospital we induce anaesthesia with i.v. midazolam and thiopental, and then maintain anaesthesia with sevo¯urane. Because both midazolam and thiopental may reduce the likelihood of seizures, we studied this anaesthesia regimen, looking for epileptiform changes in the EEG during anaesthesia induction and maintenance. We recorded EEG before premedication and continuously during anaesthesia induction and maintenance until electrocautery was used for the ®rst time.
Methods
We studied 30 children (aged 3±8 years) with ASA I physical status who were to undergo adenoidectomy in our day-case surgery unit. Patients were excluded if they had epilepsy, a history of febrile convulsions, asthma, or kidney or liver dysfunction. Data were collected between October 2000 and February 2001. The study was approved by the Ethics Committee of Kuopio University Hospital and was conducted in accordance with the latest revision of the Declaration of Helsinki. 8 All parents and children old enough were informed and gave written consent.
All children received the same anaesthesia. EMLA cream (Astra, So Èdertelje, Sweden) was used for skin analgesia. After baseline measurements, midazolam (0.1 mg kg ±1 i.v.) was given. Five minutes later, anaesthesia was induced with thiopental (5 mg kg ±1 i.v.) and tracheal intubation was facilitated by cis-atracurium (0.1 mg kg ±1 i.v.). Patients were ventilated with oxygen in air to maintain an end-tidal carbon dioxide partial pressure of 4.8±5.5 kPa. Sevo¯urane was started 3 min after the induction and adjusted to keep the end-tidal concentration at 2%. Fentanyl (1 mg kg ±1 i.v.) was given before surgery started. On completion of surgery, neuromuscular block was antagonized with neostigmine and glycopyrrolate. All children were given 5% glucose in 0.3% saline for intraoperative¯uid maintenance. Intraoperative, non-invasive arterial pressure, electrocardiography, peripheral oxygen saturation, inspiratory and end-tidal oxygen, carbon dioxide and sevo¯urane concentrations were monitored continuously by Cardiocap/5 (Datex-Ohmeda, Helsinki, Finland).
The EEG was recorded with a ®ve-channel EEG measuring machine, EMMA (developed at the Department of Clinical Neurophysiology, Kuopio University Hospital, Kuopio, Finland). The EMMA EEG machine has been validated and there are no differences compared with a standard EEG machine that could affect the results. 9 Ag/ AgCl electrodes were placed on the scalp according to the international 10±20 system. The EEG signal was recorded from the electrodes F4 and Fz which were referenced to C4¢ (2 cm behind C4). Additional M1 and O2 electrodes referenced to C4¢ were used for the ®rst 11 patients. Electrode±skin impedances were <5 kW. The signal was ampli®ed, digitized at a rate of 279 Hz and stored on a PC for off-line analysis. Baseline EEG was recorded before premedication. EEG was then recorded continuously until electrocautery was used for the ®rst time. Two children received midazolam (0.1 mg kg ±1 i.v.) and one child thiopental (1 mg kg ±1 i.v.) before baseline recordings to facilitate connection of electrodes. These three children were included in the EEG analysis as agreed in the trial protocol.
The EEG signal was inspected by two independent neurophysiologists (S W-P, J P) for detecting possible epileptiform discharges. They knew the purpose of the study, but the records were viewed with no patient details given. The EEG signal was classi®ed as fast beta activity (>13 Hz), alpha activity (8±13 Hz), theta activity (5±8 Hz) and delta activity (`4 Hz). Figure 1 shows the timing of the events during the EEG record.
After 30 min of EEG recording, a mouth gag was inserted and the adenoids were removed using a curettage technique. Haemostasis was controlled with temporary nasopharyngeal packs and by suction electrocautery when needed. After surgery, children were transferred to the post-anaesthesia care unit for continuous monitoring of vital signs and measurement of pain. Postoperative pain was treated with ketoprofen (2 mg kg ±1 i.v.), and fentanyl (1 mg kg ±1 i.v.) was used for rescue analgesia. All children were discharged after 3±4 h.
Statistical analysis
A sample size of 30 patients is commonly used in this kind of study, 2±5 and was considered suf®cient also for the present trial to detect a clinically important incidence of EEG abnormality. A sample size of 30 children has a 0.8 power to detect an incidence >27% at a signi®cance level of 0.05.
Friedman's test was used for statistical comparison of repeated measures of arterial pressure and heart rate, followed by Wilcoxon's signed-rank test with Bonferroni correction if indicated. Signi®cance was set at P<0.05.
Data are presented as mean (SD) and range as appropriate.
Results
The patients' characteristics are summarized in Table 1 . All the parents/children asked gave consent and participated in the trial. Apart from two children who received midazolam and one child who received thiopental before the baseline measurements were taken, there were no other signi®cant protocol violations. All 30 children were included in the EEG analysis. Noise-free EEG data of good quality was successfully recorded for every child. Baseline EEG was normal and the background activity was according to age. A few seconds after midazolam injection, beta activity was seen in the EEG of each patient. Thiopental injection caused a prompt appearance of high amplitude delta waves. This delta activity gradually decreased over 3 min and had almost disappeared before sevo¯urane was started.
After starting sevo¯urane inhalation the EEG showed mainly mixed delta activity with various amounts of beta waves superimposed. Occasionally, this pattern resembled delta with spikes, but epileptiform spikes were not detected. No other epileptiform EEG pattern, such as suppression with spikes, rhythmic polyspikes or periodic epileptiform discharges, was seen. During anaesthesia with sevo¯urane, the EEG showed mixed delta/theta/beta activity (Fig. 2) .
Discussion
In clinical trials, volatile anaesthetics are commonly given as single agents to avoid interaction with other drugs. However, this is not often clinical routine so we designed the present study to determine whether sevo¯urane may be used safely for anaesthesia maintenance following i.v. induction. It seems that the regimen used (i.e. premedication with midazolam, induction with thiopental and anaesthesia maintenance with sevo¯urane in oxygen/air) does not cause any epileptiform activity. Our results suggest that sevourane administration is compatible with midazolam, thiopental, fentanyl and cis-atracurium as commonly used in paediatric anaesthesia.
Midazolam is frequently used in paediatric anaesthesia. 10 In addition to anxiolysis and sedation, midazolam also has a signi®cant anticonvulsant effect 11 that makes it appropriate for co-induction with sevo¯urane. Both midazolam and thiopental increase the threshold for convulsions and reduce the incidence of EEG abnormality. An increase in beta activity seen after midazolam injection was expected because benzodiazepines are known to enhance beta activity. 12 Sevo¯urane can cause epileptiform EEG signals when used for inhalation induction with hyperventilation. Vakkuri and co-workers 4 used high sevo¯urane concentrations (8% in nitrous oxide in oxygen) for anaesthesia induction and found several forms of abnormal EEG. Suppression with spikes, rhythmic polyspikes and periodic epileptiform discharges were found in most children; the incidence of these abnormalities was 88%. In contrast, Constant and co-workers 6 did not ®nd any seizures in children during inhalation induction with three different regimens. After midazolam premedication children were given either a rapid induction with 7% sevo¯urane in oxygen; induction with incremental concentrations of sevo¯urane of 2, 4, 6 and 7% in oxygen; or induction with halothane. They found a difference between sevo¯urane and halothane. With sevourane, sharp slow waves with very fast rhythms were commonly seen, whereas slow waves and fast rhythms were observed with halothane.
Recently, an increase in the heart rate has been shown to develop during inhalation induction with various volatile anaesthetics, and higher heart rates are particularly common during concurrent epileptiform discharges. 4 6 13 14 In the present study the heart rate did not increase with sevo¯urane inhalation. However, a signi®cant increase in the heart rate and mean arterial pressure was seen during intubation, application of a mouth gag and surgical incision. This indicates that the anaesthesia used in the present study was insuf®cient to completely abolish the haemodynamic responses to nociceptive stimuli.
In previous studies, epileptiform potentials were seen during induction of anaesthesia with high sevo¯urane concentrations. In the present study the end-tidal sevourane concentration was set at 2% and no EEG problems occurred. It is not clear whether the lack of epileptiform potentials is because thiopental and midazolam were given or because a lower dose of sevo¯urane was used. We stopped recording when electrocautery was used for the ®rst time and no EEG was recorded during emergence from anaesthesia. Because a high incidence of agitation during emergence from sevo¯urane anaesthesia has been reported in previous trials, 1 it would be interesting in future to record EEG during recovery from anaesthesia.
We conclude that anaesthesia maintenance with 2% sevo¯urane in oxygen/air in children after i.v. induction with midazolam and thiopental does not elicit seizure-like changes in the EEG.
